Breaking News Instant updates and real-time market news.

CLSN

Celsion

$1.88 /

-0.02 (-1.05%)

07:32
02/22/21
02/22
07:32
02/22/21
07:32

Celsion receives FDA Fast Track Designation for GEN-1

Celsion Corporation announced that it has received Fast Track designation from the U.S. Food and Drug Administration for GEN-1, its DNA-mediated interleukin-12 immunotherapy currently in Phase II development for the treatment of advanced ovarian cancer. GEN-1 was designed using TheraPlas, Celsion's proprietary, synthetic, non-viral nanoparticle delivery system platform. GEN-1 is the subject of Celsion's Phase II OVATION 2 Study, which combines GEN-1 with standard-of-care neoadjuvant chemotherapy in patients newly diagnosed with Stage III/IV ovarian cancer. NACT is designed to shrink the cancer as much as possible for optimal surgical removal after three cycles of chemotherapy. Following NACT, patients undergo interval debulking surgery, followed by three adjuvant cycles of chemotherapy and up to nine additional weekly GEN-1 treatments, the goal of which is to delay progression and improve overall survival. The OVATION 2 Study is an open-label, 1-to-1 randomized trial, 80% powered to show the equivalent of a 33% improvement in progression-free survival, the primary endpoint, when comparing the treatment arm with the control arm. As Celsion has previously announced, it has shared with the FDA data from the Phase I portion of the Phase I/II OVATION 2 Study that showed successful tumor resections, with seven out of eight patients in the GEN-1 treatment arm having a complete tumor resection (R0), which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed. The NACT-only treatment arm had an R0 resection rate of 50%. Patients in the Company's completed Phase 1b dose-escalation OVATION I Study showed compelling objective response rates, with 100% of patients in high-dose cohorts experiencing a complete or partial response, and 67% of patients in lower-dose cohorts experiencing a complete or partial response. Further, R0 resections in the high-dose cohorts was 88%, compared with 33% in the low-dose cohorts. In addition, Celsion compared matched patient data in a synthetic control arm with results from the OVATION I Study. Patients in the GEN-1 arm virtually demonstrated a doubling of control of their cancer compared with the synthetic control arm. Findings are not statistically significant due to the small number of patients.

CLSN Celsion
$1.88 /

-0.02 (-1.05%)

07/16/20 Oppenheimer
Celsion downgraded to Perform at Oppenheimer
07/16/20 Oppenheimer
Celsion downgraded to Perform from Outperform at Oppenheimer
07/14/20 Dawson James
Celsion downgraded to Hold from Buy at Dawson James

TODAY'S FREE FLY STORIES

Hot Stocks
Surgalign announces date change for Q4, FY20 earnings release » 09:01
03/05/21
03/05
09:01
03/05/21
09:01
SRGA

Surgalign

$2.32 /

-0.21 (-8.32%)

Surgalign Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRGA Surgalign
$2.32 /

-0.21 (-8.32%)

SRGA Surgalign
$2.32 /

-0.21 (-8.32%)

02/03/21
Fly Intel: Top five analyst initiations
02/03/21 BTIG
Surgalign initiated with a Buy at BTIG
02/02/21 Piper Sandler
Surgalign initiated with an Overweight at Piper Sandler
11/30/20
Fly Intel: Top five analyst initiations
  • 28
    Jan
Hot Stocks
Abbott receives FDA EUA for Alinity m Resp-4-Plex molecular assay » 09:01
03/05/21
03/05
09:01
03/05/21
09:01
ABT

Abbott

$115.91 /

-3.27 (-2.74%)

Abbott announced U.S. FDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$115.91 /

-3.27 (-2.74%)

ABT Abbott
$115.91 /

-3.27 (-2.74%)

01/28/21
Fly Intel: Top five analyst upgrades
01/28/21 Cowen
Abbott price target raised to $140 from $113 at Cowen
01/28/21 SVB Leerink
Abbott price target raised to $128 from $115 at SVB Leerink
01/28/21 Credit Suisse
Abbott price target raised to $130 from $118 at Credit Suisse
ABT Abbott
$115.91 /

-3.27 (-2.74%)

ABT Abbott
$115.91 /

-3.27 (-2.74%)

ABT Abbott
$115.91 /

-3.27 (-2.74%)

ABT Abbott
$115.91 /

-3.27 (-2.74%)

Recommendations
New York Community Bancorp price target raised to $15 from $14 at B. Riley » 09:01
03/05/21
03/05
09:01
03/05/21
09:01
NYCB

New York Community Bancorp

$12.07 /

-0.08 (-0.66%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NYCB New York Community Bancorp
$12.07 /

-0.08 (-0.66%)

NYCB New York Community Bancorp
$12.07 /

-0.08 (-0.66%)

02/05/21
New York Community Bancorp cut to Neutral at UBS on waning NIM expansion
01/15/21 Compass Point
New York Community Bancorp upgraded to Buy from Neutral at Compass Point
11/06/20 Morgan Stanley
New York Community Bancorp upgraded to Equal Weight at Morgan Stanley
11/06/20 Morgan Stanley
New York Community upgraded to Equal Weight from Underweight at Morgan Stanley
NYCB New York Community Bancorp
$12.07 /

-0.08 (-0.66%)

NYCB New York Community Bancorp
$12.07 /

-0.08 (-0.66%)

Hot Stocks
Verizon announces Verizon Women's CoLab » 09:00
03/05/21
03/05
09:00
03/05/21
09:00
VZ

Verizon

$54.80 /

-0.58 (-1.05%)

Verizon announced Verizon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZ Verizon
$54.80 /

-0.58 (-1.05%)

VZ Verizon
$54.80 /

-0.58 (-1.05%)

03/04/21 Wells Fargo
Wells Fargo sees Dycom near-term growth priced in, cuts rating to Equal Weight
02/25/21
Fly Intel: Pre-market Movers
02/25/21 Scotiabank
Verizon downgraded to Sector Perform from Outperform at Scotiabank
02/25/21 Oppenheimer
Verizon, AT&T downgraded to Perform on valuation at Oppenheimer
VZ Verizon
$54.80 /

-0.58 (-1.05%)

VZ Verizon
$54.80 /

-0.58 (-1.05%)

VZ Verizon
$54.80 /

-0.58 (-1.05%)

VZ Verizon
$54.80 /

-0.58 (-1.05%)

Recommendations
First Foundation price target raised to $28 from $26 at B. Riley Securities » 09:00
03/05/21
03/05
09:00
03/05/21
09:00
FFWM

First Foundation

$23.13 /

-0.41 (-1.74%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FFWM First Foundation
$23.13 /

-0.41 (-1.74%)

01/07/21 B. Riley Securities
First Foundation price target raised to $26 from $25 at B. Riley Securities
12/16/20 B. Riley Securities
First Foundation price target raised to $25 from $23 at B. Riley Securities
12/04/20 B. Riley Securities
First Foundation price target raised to $23 from $21 at B. Riley Securities
07/22/20 B. Riley FBR
First Foundation price target raised to $21 from $19 at B. Riley FBR
FFWM First Foundation
$23.13 /

-0.41 (-1.74%)

General news
Treasury Action: yields popped on the generally stronger than expected jobs report » 09:00
03/05/21
03/05
09:00
03/05/21
09:00

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Joint Corp. price target raised to $60 from $35 at Lake Street » 08:59
03/05/21
03/05
08:59
03/05/21
08:59
JYNT

Joint Corp.

$44.28 /

-4.77 (-9.72%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JYNT Joint Corp.
$44.28 /

-4.77 (-9.72%)

JYNT Joint Corp.
$44.28 /

-4.77 (-9.72%)

08:07 Today Maxim
Joint Corp. price target raised to $54 from $28 at Maxim
02/25/21 B. Riley Securities
Joint Corp. price target raised to $47 from $26 at B. Riley Securities
01/06/21 Craig-Hallum
Joint Corp. price target raised to $38 from $26 at Craig-Hallum
01/04/21 Lake Street
Joint Corp. price target raised to $35 from $25 at Lake Street
JYNT Joint Corp.
$44.28 /

-4.77 (-9.72%)

Conference/Events
Deutsche Bank medical tech analyst to hold an analyst/industry conference call » 08:59
03/05/21
03/05
08:59
03/05/21
08:59
BSX

Boston Scientific

$37.92 /

-0.845 (-2.18%)

Medical Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BSX Boston Scientific
$37.92 /

-0.845 (-2.18%)

BSX Boston Scientific
$37.92 /

-0.845 (-2.18%)

03/03/21 Piper Sandler
Piper Sandler still positively inclined on Boston Scientific after Lumenis deal
02/03/21 Piper Sandler
Boston Scientific price target raised to $48 from $46 at Piper Sandler
02/01/21
Fly Intel: Top five analyst initiations
02/01/21 Deutsche Bank
Boston Scientific initiated with a Hold at Deutsche Bank
BSX Boston Scientific
$37.92 /

-0.845 (-2.18%)

  • 22
    May
BSX Boston Scientific
$37.92 /

-0.845 (-2.18%)

BSX Boston Scientific
$37.92 /

-0.845 (-2.18%)

Downgrade
Comerica downgraded to Neutral on valuation at B. Riley Securities » 08:58
03/05/21
03/05
08:58
03/05/21
08:58
CMA

Comerica

$68.29 /

-1.56 (-2.23%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMA Comerica
$68.29 /

-1.56 (-2.23%)

CMA Comerica
$68.29 /

-1.56 (-2.23%)

07:07 Today B. Riley Securities
Comerica downgraded to Neutral from Buy at B. Riley Securities
01/20/21 DA Davidson
Comerica price target raised to $62 from $50 at DA Davidson
01/20/21 Truist
Comerica price target raised to $67 from $56 at Truist
01/20/21 B. Riley Securities
Comerica price target raised to $72 from $65 at B. Riley Securities
CMA Comerica
$68.29 /

-1.56 (-2.23%)

CMA Comerica
$68.29 /

-1.56 (-2.23%)

Recommendations
Fortress Transportation price target raised to $37 from $31 at B. Riley » 08:57
03/05/21
03/05
08:57
03/05/21
08:57
FTAI

Fortress Transportation

$29.16 /

-0.42 (-1.42%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTAI Fortress Transportation
$29.16 /

-0.42 (-1.42%)

FTAI Fortress Transportation
$29.16 /

-0.42 (-1.42%)

03/01/21 Barclays
Fortress Transportation price target raised to $30 from $23 at Barclays
02/23/21 JMP Securities
Fortress Transportation price target raised to $32 from $22 at JMP Securities
02/22/21 B. Riley Securities
Fortress Transportation price target raised to $31 from $27 at B. Riley
02/01/21 Barclays
Fortress Transportation price target raised to $23 from $20 at Barclays
FTAI Fortress Transportation
$29.16 /

-0.42 (-1.42%)

FTAI Fortress Transportation
$29.16 /

-0.42 (-1.42%)

Hot Stocks
SuperCom reports successful coronavirus quarantine compliance pilot in Israel » 08:56
03/05/21
03/05
08:56
03/05/21
08:56
SPCB

SuperCom

$1.17 /

-0.21 (-15.27%)

SuperCom announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPCB SuperCom
$1.17 /

-0.21 (-15.27%)

Recommendations
Smith & Wesson Brands price target raised to $34 from $28 at Lake Street » 08:56
03/05/21
03/05
08:56
03/05/21
08:56
SWBI

Smith & Wesson Brands

$15.79 /

-0.54 (-3.31%)

Lake Street analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

08:37 Today Craig-Hallum
Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum
07:12 Today Craig-Hallum
Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum
03/04/21 B. Riley Securities
B. Riley starts American Outdoor Brands with Buy, $32 price target
12/04/20 Lake Street
Lake Street ups Smith & Wesson Brands price target to $28 after earnings
SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

Recommendations
Purple Innovation selloff 'attractive buying opportunity,' says B. Riley » 08:55
03/05/21
03/05
08:55
03/05/21
08:55
PRPL

Purple Innovation

$24.42 /

-11.76 (-32.50%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

08:09 Today Wedbush
Purple Innovation price target lowered to $32 from $38 at Wedbush
08:05 Today Raymond James
Purple Innovation price target lowered to $32 from $36 at Raymond James
06:21 Today UBS
Purple Innovation price target lowered to $32 from $44 at UBS
01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

Options
Notable open interest changes for March 5th » 08:55
03/05/21
03/05
08:55
03/05/21
08:55
PLTR

Palantir

$24.75 /

+1.15 (+4.87%)

, AAPL

Apple

$120.26 /

-1.81 (-1.48%)

, GE

General Electric

$13.57 /

+0.135 (+1.00%)

, NIO

NIO

$39.33 /

-2.2 (-5.30%)

Thursday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$24.75 /

+1.15 (+4.87%)

AAPL Apple
$120.26 /

-1.81 (-1.48%)

GE General Electric
$13.57 /

+0.135 (+1.00%)

NIO NIO
$39.33 /

-2.2 (-5.30%)

PLTR Palantir
$24.75 /

+1.15 (+4.87%)

02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
02/17/21 Jefferies
Palantir 'a highly unique story for long-term investors,' says Jefferies
02/17/21 Morgan Stanley
Palantir price target raised to $19 from $17 at Morgan Stanley
AAPL Apple
$120.26 /

-1.81 (-1.48%)

03/01/21 Wedbush
Asia checks bullish for Apple iPhone 12 builds, says Wedbush
03/01/21 JPMorgan
Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan
02/25/21 JPMorgan
JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts
02/24/21 Piper Sandler
Piper sees Apple developing 'full-blown' branded electric vehicle
GE General Electric
$13.57 /

+0.135 (+1.00%)

03/04/21 Morgan Stanley
General Electric price target raised to $17 from $13 at Morgan Stanley
03/02/21 Barclays
Danaher started at Overweight at Barclays on GE biopharma business potential
02/22/21 Goldman Sachs
General Electric price target raised to $15 at Goldman Sachs after meetings
01/28/21 Barclays
General Electric price target raised to $13 from $12 at Barclays
NIO NIO
$39.33 /

-2.2 (-5.30%)

03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
PLTR Palantir
$24.75 /

+1.15 (+4.87%)

AAPL Apple
$120.26 /

-1.81 (-1.48%)

GE General Electric
$13.57 /

+0.135 (+1.00%)

NIO NIO
$39.33 /

-2.2 (-5.30%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
PLTR Palantir
$24.75 /

+1.15 (+4.87%)

AAPL Apple
$120.26 /

-1.81 (-1.48%)

GE General Electric
$13.57 /

+0.135 (+1.00%)

NIO NIO
$39.33 /

-2.2 (-5.30%)

PLTR Palantir
$24.75 /

+1.15 (+4.87%)

AAPL Apple
$120.26 /

-1.81 (-1.48%)

GE General Electric
$13.57 /

+0.135 (+1.00%)

NIO NIO
$39.33 /

-2.2 (-5.30%)

PLTR Palantir
$24.75 /

+1.15 (+4.87%)

AAPL Apple
$120.26 /

-1.81 (-1.48%)

GE General Electric
$13.57 /

+0.135 (+1.00%)

NIO NIO
$39.33 /

-2.2 (-5.30%)

Recommendations
Cohu price target raised to $74 from $72 at B. Riley Securities » 08:53
03/05/21
03/05
08:53
03/05/21
08:53
COHU

Cohu

$39.45 /

-2.57 (-6.12%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COHU Cohu
$39.45 /

-2.57 (-6.12%)

COHU Cohu
$39.45 /

-2.57 (-6.12%)

02/12/21 Craig-Hallum
Cohu price target raised to $73 from $45 at Craig-Hallum
02/12/21 B. Riley Securities
Cohu price target raised to $72 from $60 at B. Riley Securities
02/10/21 B. Riley Securities
B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
01/25/21 B. Riley Securities
Cohu price target raised to $60 from $46 at B. Riley Securities
COHU Cohu
$39.45 /

-2.57 (-6.12%)

  • 04
    Mar
COHU Cohu
$39.45 /

-2.57 (-6.12%)

Downgrade
Martinrea downgraded to Outperform from Strong Buy at Raymond James » 08:51
03/05/21
03/05
08:51
03/05/21
08:51
MRETF

Martinrea

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRETF Martinrea
$0.00 /

+ (+0.00%)

MRETF Martinrea
$0.00 /

+ (+0.00%)

02/03/21 CIBC
Martinrea price target raised to C$21 from C$20 at CIBC
01/21/21 Scotiabank
Martinrea price target raised to C$19.50 from C$19 at Scotiabank
12/18/20 TD Securities
Martinrea price target raised to C$22 from C$18 at TD Securities
12/07/20 CIBC
Martinrea price target raised to C$20 from C$16.50 at CIBC
Upgrade
Mohawk Group upgraded to Buy from Neutral at Sidoti » 08:50
03/05/21
03/05
08:50
03/05/21
08:50
MWK

Mohawk Group

/

+

Sidoti analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MWK Mohawk Group
/

+

MWK Mohawk Group
/

+

02/18/21 Sidoti
Mohawk Group downgraded to Neutral from Buy at Sidoti
02/09/21 Oppenheimer
Mohawk Group price target raised to $50 from $30 at Oppenheimer
02/03/21 Roth Capital
Mohawk Group price target raised to $37 from $16 at Roth Capital
02/02/21 Alliance Global Partners
Mohawk Group price target raised to $34 from $20 at Alliance Global Partners
MWK Mohawk Group
/

+

MWK Mohawk Group
/

+

MWK Mohawk Group
/

+

Recommendations
Bally's expansion progress overshadows results, says Macquarie » 08:50
03/05/21
03/05
08:50
03/05/21
08:50
BALY

Bally's

$52.30 /

-8.27 (-13.65%)

Macquarie analyst Jordan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BALY Bally's
$52.30 /

-8.27 (-13.65%)

BALY Bally's
$52.30 /

-8.27 (-13.65%)

06:55 Today Stifel
Stifel upgrades Bally's to Buy after 'overplayed' post-earnings dip
05:30 Today Stifel
Bally's upgraded to Buy from Hold at Stifel
02/24/21 Truist
Bally's price target raised to $80 from $65 at Truist
02/09/21 Stifel
Bally's price target raised to $60 from $50 at Stifel
BALY Bally's
$52.30 /

-8.27 (-13.65%)

BALY Bally's
$52.30 /

-8.27 (-13.65%)

BALY Bally's
$52.30 /

-8.27 (-13.65%)

Initiation
Limbach Holding initiated with a Buy at Lake Street » 08:49
03/05/21
03/05
08:49
03/05/21
08:49
LMB

Limbach Holding

$11.46 /

-0.54 (-4.50%)

Lake Street analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMB Limbach Holding
$11.46 /

-0.54 (-4.50%)

  • 11
    Feb
Hot Stocks
Ocuphire Pharma announces publication of MIRA-1 Phase 2b results » 08:49
03/05/21
03/05
08:49
03/05/21
08:49
OCUP

Ocuphire Pharma

$9.24 /

-0.91 (-8.97%)

Ocuphire Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$9.24 /

-0.91 (-8.97%)

OCUP Ocuphire Pharma
$9.24 /

-0.91 (-8.97%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Canaccord
Canaccord starts Ocuphire Pharma at Buy on lead asset's potential
02/10/21 Canaccord
Ocuphire Pharma initiated with a Buy at Canaccord
11/19/20 Cantor Fitzgerald
Ocuphire Pharma initiated with an Overweight at Cantor Fitzgerald
Recommendations
Imax price target raised to $25 after Q4 earnings beat at Macquarie » 08:47
03/05/21
03/05
08:47
03/05/21
08:47
IMAX

Imax

$20.78 /

-0.98 (-4.50%)

Macquarie analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMAX Imax
$20.78 /

-0.98 (-4.50%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

06:49 Today Benchmark
Imax price target raised to $24 from $22 at Benchmark
03/01/21 Wedbush
Imax price target raised to $22 from $14 at Wedbush
02/16/21 B. Riley Securities
IMAX format positioned to gain post-pandemic share, says B. Riley Securities
02/16/21 Macquarie
Imax remains best way to play theatrical space, says Macquarie
IMAX Imax
$20.78 /

-0.98 (-4.50%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

Recommendations
Marriott Vacations price target raised to $184 from $151 at Truist » 08:46
03/05/21
03/05
08:46
03/05/21
08:46
VAC

Marriott Vacations

$167.50 /

-1.66 (-0.98%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VAC Marriott Vacations
$167.50 /

-1.66 (-0.98%)

VAC Marriott Vacations
$167.50 /

-1.66 (-0.98%)

03/02/21 Stifel
Marriott Vacations price target raised to $185 from $178 at Stifel
02/26/21 Deutsche Bank
Marriott Vacations price target raised to $158 from $128 at Deutsche Bank
02/01/21 Credit Suisse
Marriott Vacations price target raised to $199 from $145 at Credit Suisse
01/28/21 Jefferies
Marriott Vacations price target raised to $174 from $165 at Jefferies
VAC Marriott Vacations
$167.50 /

-1.66 (-0.98%)

VAC Marriott Vacations
$167.50 /

-1.66 (-0.98%)

Recommendations
Travel + Leisure price target raised to $74 from $62 at Truist » 08:46
03/05/21
03/05
08:46
03/05/21
08:46
TNL

Travel + Leisure

$57.95 /

-1.035 (-1.75%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNL Travel + Leisure
$57.95 /

-1.035 (-1.75%)

02/26/21 Deutsche Bank
Marriott Vacations price target raised to $158 from $128 at Deutsche Bank
02/25/21 Deutsche Bank
Travel + Leisure price target raised to $69 from $63 at Deutsche Bank
TNL Travel + Leisure
$57.95 /

-1.035 (-1.75%)

General news
U.S. nonfarm payrolls increased 379k in February » 08:45
03/05/21
03/05
08:45
03/05/21
08:45

U.S. nonfarm payrolls…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Hilton Grand Vacations price target raised to $48 from $36 at Truist » 08:45
03/05/21
03/05
08:45
03/05/21
08:45
HGV

Hilton Grand Vacations

/

+

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HGV Hilton Grand Vacations
/

+

09/08/20 Goldman Sachs
Hilton Grand Vacations upgraded to Buy from Neutral at Goldman Sachs
05/21/20 Credit Suisse
Hilton Grand Vacations assumed with an Outperform at Credit Suisse
HGV Hilton Grand Vacations
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.